125 related articles for article (PubMed ID: 23178857)
1. Krüppel-like factor 10 upregulates the expression of cyclooxygenase 1 and further modulates angiogenesis in endothelial cell and platelet aggregation in gene-deficient mice.
Yang DH; Hsu CF; Lin CY; Guo JY; Yu WC; Chang VH
Int J Biochem Cell Biol; 2013 Feb; 45(2):419-28. PubMed ID: 23178857
[TBL] [Abstract][Full Text] [Related]
2. TGF-β1 signaling and Krüppel-like factor 10 regulate bone marrow-derived proangiogenic cell differentiation, function, and neovascularization.
Wara AK; Foo S; Croce K; Sun X; Icli B; Tesmenitsky Y; Esen F; Lee JS; Subramaniam M; Spelsberg TC; Lev EI; Leshem-Lev D; Pande RL; Creager MA; Rosenzweig A; Feinberg MW
Blood; 2011 Dec; 118(24):6450-60. PubMed ID: 21828131
[TBL] [Abstract][Full Text] [Related]
3. Klf10 induces cell apoptosis through modulation of BI-1 expression and Ca2+ homeostasis in estrogen-responding adenocarcinoma cells.
Hsu CF; Sui CL; Wu WC; Wang JJ; Yang DH; Chen YC; Yu WC; Chang HS
Int J Biochem Cell Biol; 2011 Apr; 43(4):666-73. PubMed ID: 21262377
[TBL] [Abstract][Full Text] [Related]
4. Krüppel-like factor KLF10 regulates transforming growth factor receptor II expression and TGF-β signaling in CD8+ T lymphocytes.
Papadakis KA; Krempski J; Reiter J; Svingen P; Xiong Y; Sarmento OF; Huseby A; Johnson AJ; Lomberk GA; Urrutia RA; Faubion WA
Am J Physiol Cell Physiol; 2015 Mar; 308(5):C362-71. PubMed ID: 25472963
[TBL] [Abstract][Full Text] [Related]
5. KLF10 affects pancreatic function via the SEI-1/p21Cip1 pathway.
Wu MJ; Wu WC; Chang HW; Lai YT; Lin CH; Yu WC; Chang VH
Int J Biochem Cell Biol; 2015 Mar; 60():53-9. PubMed ID: 25578559
[TBL] [Abstract][Full Text] [Related]
6. KLF10, transforming growth factor-β-inducible early gene 1, acts as a tumor suppressor.
Song KD; Kim DJ; Lee JE; Yun CH; Lee WK
Biochem Biophys Res Commun; 2012 Mar; 419(2):388-94. PubMed ID: 22349513
[TBL] [Abstract][Full Text] [Related]
7. Cyclooxygenase-2-selective nonsteroidal anti-inflammatory drugs inhibit hepatocyte growth factor/scatter factor-induced angiogenesis.
Sengupta S; Sellers LA; Cindrova T; Skepper J; Gherardi E; Sasisekharan R; Fan TP
Cancer Res; 2003 Dec; 63(23):8351-9. PubMed ID: 14678996
[TBL] [Abstract][Full Text] [Related]
8. Krüppel-like factor 10 expression as a prognostic indicator for pancreatic adenocarcinoma.
Chang VH; Chu PY; Peng SL; Mao TL; Shan YS; Hsu CF; Lin CY; Tsai KK; Yu WC; Ch'ang HJ
Am J Pathol; 2012 Aug; 181(2):423-30. PubMed ID: 22688058
[TBL] [Abstract][Full Text] [Related]
9. Tumor necrosis factor-alpha receptor p75 is required in ischemia-induced neovascularization.
Goukassian DA; Qin G; Dolan C; Murayama T; Silver M; Curry C; Eaton E; Luedemann C; Ma H; Asahara T; Zak V; Mehta S; Burg A; Thorne T; Kishore R; Losordo DW
Circulation; 2007 Feb; 115(6):752-62. PubMed ID: 17261656
[TBL] [Abstract][Full Text] [Related]
10. Klf10 and Klf11 as mediators of TGF-beta superfamily signaling.
Spittau B; Krieglstein K
Cell Tissue Res; 2012 Jan; 347(1):65-72. PubMed ID: 21574058
[TBL] [Abstract][Full Text] [Related]
11. A novel vasculo-angiogenic effect of cilostazol mediated by cross-talk between multiple signalling pathways including the ERK/p38 MAPK signalling transduction cascade.
Chao TH; Tseng SY; Li YH; Liu PY; Cho CL; Shi GY; Wu HL; Chen JH
Clin Sci (Lond); 2012 Aug; 123(3):147-59. PubMed ID: 22339730
[TBL] [Abstract][Full Text] [Related]
12. Functional role of KLF10 in multiple disease processes.
Subramaniam M; Hawse JR; Rajamannan NM; Ingle JN; Spelsberg TC
Biofactors; 2010; 36(1):8-18. PubMed ID: 20087894
[TBL] [Abstract][Full Text] [Related]
13. Klf10 deficiency in mice exacerbates pulmonary inflammation by increasing expression of the proinflammatory molecule NPRA.
Huang LT; Chang HW; Wu MJ; Lai YT; Wu WC; Yu WCY; Chang VHS
Int J Biochem Cell Biol; 2016 Oct; 79():231-238. PubMed ID: 27592451
[TBL] [Abstract][Full Text] [Related]
14. Repression of myoblast proliferation and fibroblast growth factor receptor 1 promoter activity by KLF10 protein.
Parakati R; DiMario JX
J Biol Chem; 2013 May; 288(19):13876-84. PubMed ID: 23569208
[TBL] [Abstract][Full Text] [Related]
15. In mice with type 2 diabetes, a vascular endothelial growth factor (VEGF)-activating transcription factor modulates VEGF signaling and induces therapeutic angiogenesis after hindlimb ischemia.
Li Y; Hazarika S; Xie D; Pippen AM; Kontos CD; Annex BH
Diabetes; 2007 Mar; 56(3):656-65. PubMed ID: 17327433
[TBL] [Abstract][Full Text] [Related]
16. Activation of fractalkine/CX3CR1 by vascular endothelial cells induces angiogenesis through VEGF-A/KDR and reverses hindlimb ischaemia.
Ryu J; Lee CW; Hong KH; Shin JA; Lim SH; Park CS; Shim J; Nam KB; Choi KJ; Kim YH; Han KH
Cardiovasc Res; 2008 May; 78(2):333-40. PubMed ID: 18006432
[TBL] [Abstract][Full Text] [Related]
17. Intermedin: a novel regulator for vascular remodeling and tumor vessel normalization by regulating vascular endothelial-cadherin and extracellular signal-regulated kinase.
Zhang W; Wang LJ; Xiao F; Wei Y; Ke W; Xin HB
Arterioscler Thromb Vasc Biol; 2012 Nov; 32(11):2721-32. PubMed ID: 22922959
[TBL] [Abstract][Full Text] [Related]
18. In vivo evidence of angiogenesis induced by transcription factor Ets-1: Ets-1 is located upstream of angiogenesis cascade.
Hashiya N; Jo N; Aoki M; Matsumoto K; Nakamura T; Sato Y; Ogata N; Ogihara T; Kaneda Y; Morishita R
Circulation; 2004 Jun; 109(24):3035-41. PubMed ID: 15173033
[TBL] [Abstract][Full Text] [Related]
19. Discovery of small molecule inhibitors to Krüppel-like factor 10 (KLF10): implications for modulation of T regulatory cell differentiation.
Khedkar SA; Sun X; Rigby AC; Feinberg MW
J Med Chem; 2015 Feb; 58(3):1466-78. PubMed ID: 25581017
[TBL] [Abstract][Full Text] [Related]
20. An engineered vascular endothelial growth factor-activating transcription factor induces therapeutic angiogenesis in ApoE knockout mice with hindlimb ischemia.
Xie D; Li Y; Reed EA; Odronic SI; Kontos CD; Annex BH
J Vasc Surg; 2006 Jul; 44(1):166-75. PubMed ID: 16753278
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
